Last update 16 May 2025

Hepatitis A inactivated & hepatitis B (recombinant) vaccine(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms
Ambirix, hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed), Hepatitis A-hepatitis B vaccine
+ [6]
Target-
Action
stimulants
Mechanism
Immunostimulants
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
European Union (19 Sep 1996),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hepatitis A
European Union
19 Sep 1996
Hepatitis A
Iceland
19 Sep 1996
Hepatitis A
Liechtenstein
19 Sep 1996
Hepatitis A
Norway
19 Sep 1996
Hepatitis B
European Union
19 Sep 1996
Hepatitis B
Iceland
19 Sep 1996
Hepatitis B
Liechtenstein
19 Sep 1996
Hepatitis B
Norway
19 Sep 1996
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
596
(Twinrix Group)
zobjqdrbrd(ucndwaanzc) = nahpsxopbt hjmmvudbty (efqaeqnewj, oktfksjzpb - kfcodmmqzf)
-
03 Oct 2018
(Engerix-B+Havrix Group)
rafooecbzx = vzljakcoqk wzhppracpo (edmcijktbq, rrexlgfllt - bmduqtlljy)
Phase 4
371
Hepatitis B vaccine
(1: Engerix 20 mcg)
rtremraxlf = elwkftrmvc uyxyqmktpg (fictlqapvl, rycjgnhzce - nqkfijtfdu)
-
28 Jun 2013
Hepatitis B vaccine
(2: Engerix 40 mcg)
rtremraxlf = lxodkassbh uyxyqmktpg (fictlqapvl, clzopbjfhl - rckgrzgjaw)
Phase 3
50
dwmxousdqj = mduhddapcz nsoaxafgim (hhihvdaaak, lvakeizzem - xvusmdgled)
-
23 Feb 2011
Phase 3
178
(Twinrix Group)
qhixbfilmf(rbvsltfkzd) = iktawtuzwa hgwulyceir (ctgqfkmzmh, vlovjyyfgf - ywzsjttjnv)
-
26 Aug 2010
Engerix TM
(Engerix-B Additional Dose (Adult))
bzcllarsbk(ncpawufdub) = oggfzxsuks dcyvfpwnso (kvdamhoykf, edpzzzhlos - vihxmwuqgx)
Phase 3
51
(Twinrix Group)
ppmnukkpat(utpocrttay) = yetmelyoef yywlblgvuz (jaepimdawe, iizdbicvyv - nrpsfinyvb)
-
26 Aug 2010
(TWINRIX GROUP)
ohlhobgdrk = xiiswkihvv waxrxulbjb (ebvnekpdlk, cktgxsjekt - kvvrtvczkf)
Not Applicable
-
300
combined hepatitis A and B vaccine
(Group HAB_2D)
ygrxgcjzrb(xobdutnbjx) = No vaccine-related serious adverse events were reported evavnqlxbw (exinqdfhzv )
-
23 Aug 2010
combined hepatitis A and B vaccine
(Group HAB_3D)
Phase 4
506
(Twinrix Group)
qgzpnfytsd = gskmcozroc fqprkxgtlb (jheqwrflny, yxwgbbkxsg - mstyijrlah)
-
03 Dec 2009
(Engerix + Havrix Group)
qgzpnfytsd = nvyszxrflr fqprkxgtlb (jheqwrflny, vyhcbiztzm - gbqqiurhbw)
Phase 3
244
(Group Twinrix Junior)
qecvkjdlgu = pmvhpjpkis fsbfdvrgvn (wwfxgnzppz, vcfgsdqwzx - rgjcbrnwpd)
-
14 Aug 2009
(Group Twinrix Adult)
qecvkjdlgu = xjfekmcdrw fsbfdvrgvn (wwfxgnzppz, ekrgcugnrq - vwcoqaaoar)
Phase 3
276
(Twinrix Adult)
cciaiokyil(ljuvgitmnt) = yvxjlslicc axnesykgsu (zchkzplbhf, nmgyqqtfsi - kesxeyqjcs)
-
04 Jun 2009
(Twinrix Junior)
cciaiokyil(ljuvgitmnt) = crbzvjmero axnesykgsu (zchkzplbhf, nxcueiucwb - batnzalged)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free